Steve Schonfeld’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Steve Schonfeld’s Portfolio ASLN Stock Details ASLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-15,538	Closed	-$37.3K	–	2567
2024 Q2	$37.3K	Sell	15,538 -2,887	-16%	-$10.2K	﹤0.01%	1962
2024 Q1	$90.7K	Buy	18,425 +14,962	+432%	+$75K	﹤0.01%	1858
2023 Q4	$14.5K	Sell	3,463 -7,975	-70%	-$60.2K	﹤0.01%	1707
2023 Q3	$172K	Buy	11,438 +4,638	+68%	+$85.1K	﹤0.01%	1439
2023 Q2	$199K	Buy	+6,800	New	+$210K	﹤0.01%	1575
2021 Q3	–	Sell	-1,138	Closed	-$150K	–	2553
2021 Q2	$150K	Sell	1,138 -122	-10%	-$15.3K	﹤0.01%	1739
2021 Q1	$168K	Buy	+1,260	New	+$160K	﹤0.01%	1560

Other funds holding ASLN

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Steve Schonfeld's ASLN Position: Q3 2024 in Review

Steve Schonfeld sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q3 2024, closing a stake of 15,538 shares — an estimated $37.3K sold.

Steve Schonfeld first reported a position in ASLN in Q1 2021 and held it in 7 quarters. The position peaked at $199K in Q2 2023. 1 fund tracked by Wall St. Rank holds ASLN as of Q3 2024.

Steve Schonfeld reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q3 2024 after selling out during the quarter.
Steve Schonfeld sold 15,538 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q3 2024, an estimated $37.3K.
Steve Schonfeld first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q1 2021 and held it in 7 quarters.
Steve Schonfeld's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $199K in Q2 2023.
1 fund tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q3 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.